Molnupiravir benefits outweigh risk among Covid patients: Experts
An expert panel of the Central Drugs Standard Control Organisation had recently approved the antiviral Molnupiravir for restricted use in emergency situations, However, ICMR has raised concern over its side effects.
Jan 11, 2022, 10:44 AM IST
Covid antiviral oral pill Molnupiravir launched in India; Price, dosage, all you need to know
Molnupiravir is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat COVID-19 in those infected by SARS-CoV-2.
Jan 04, 2022, 17:32 PM IST
Corbevax, Covovax, Molnupiravir: All about India's 3 new COVID19 vaccines, how they will be administered
Six COVID-19 vaccines - Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson - had already received EUA from the Indian drug regulator earlier.
Dec 29, 2021, 07:35 AM IST
India gets two more COVID-19 vaccines as CORBEVAX, COVOVAX approved for emergency use authorisation
Molnupiravir, an anti-viral drug, has also been approved for restricted use in an emergency situation.
Dec 28, 2021, 11:19 AM IST
UK approves world's first pill to treat Covid-19. Here's all you need to know
United Kingdom on Thursday became the first country in the world to approve a pill treatment for Covid-19. Developed by Merck and Ridgeback Biotherapeutics the antiviral is called "molnupiravir".
Nov 05, 2021, 16:12 PM IST
5 Indian pharma companies would jointly conduct a clinical trial of COVID drug
They would carry out a clinical trial of Merck & Co's anti-viral drug to treat mild COVID-19 in non-hospitalised patients in India
Jun 29, 2021, 17:32 PM IST
COVID-19: New study claims this antiviral drug blocks coronavirus within 24 hours
Researchers have discovered that the treatment of SARS-CoV-2 infection (Covid-19) with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses the virus transmission within 24 hours.
Dec 06, 2020, 17:14 PM IST
